Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, A. R.
Right arrow Articles by Eshleman, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, A. R.
Right arrow Articles by Eshleman, J. R.
[Cancer Research 62, 7230-7233, December 15, 2002]
© 2002 American Association for Cancer Research


Carcinogenesis

8-Hydroxyguanosine Repair Is Defective in Some Microsatellite Stable Colorectal Cancer Cells1

Antony R. Parker, Robert N. O’Meally, Dwight H. Oliver2, Li Hua, William G. Nelson, Theodore L. DeWeese and James R. Eshleman3

Departments of Pathology [A. R. P., D. H. O., L. H., J. R. E.], Oncology [W. G. N., T. L. D., J. R. E.], Urology [R. N. O., W. G. N., T. L. D.], and Pharmacology and Medicine [W. G. N.], Johns Hopkins University, Baltimore, Maryland 21205

Mutator phenotypes are involved in the carcinogenesis of some cancers, e.g., defects in mismatch repair produce a mutator phenotype that drives carcinogenesis and causes microsatellite instability in hereditary nonpolyposis colon cancers and some sporadic colorectal cancers (CRC). Less understood, however, is the potential role of mutator phenotypes in microsatellite stable (MSS) CRC carcinogenesis. A novel transversion mutator phenotype was reported recently in an MSS CRC cell line. We hypothesized that 8-hydroxyguanosine could be involved and found elevations in 5 of 15 (33%) MSS CRC cell lines analyzed. Repair of an adenine{bullet}8-hydroxyguanosine mispair was functionally defective in the same five cell lines. The human MutY homologue transcript and MutY homologue protein levels were also decreased. These findings may reflect a MSS mutator phenotype contributing to the development of CRC.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
J. W. Hill and M. K. Evans
Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase
Nucleic Acids Res., March 20, 2006; 34(5): 1620 - 1632.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Ouyang, T. L. DeWeese, W. G. Nelson, and C. Abate-Shen
Loss-of-Function of Nkx3.1 Promotes Increased Oxidative Damage in Prostate Carcinogenesis
Cancer Res., August 1, 2005; 65(15): 6773 - 6779.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Parker, R. N. O'Meally, F. Sahin, G. H. Su, F. K. Racke, W. G. Nelson, T. L. DeWeese, and J. R. Eshleman
Defective Human MutY Phosphorylation Exists in Colorectal Cancer Cell Lines with Wild-type MutY Alleles
J. Biol. Chem., November 28, 2003; 278(48): 47937 - 47945.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.